Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Transplantation Market Projected to be Worth USD 117.89 billion by 2021: Technavio

Technavio Research
Posted on: 03 May 17

According to the latest market study released by Technavio, the global transplantation marketis projected to grow to USD 117.89 billion by 2021, at a CAGR of close to 10% over the forecast period.

This Smart News Release features multimedia. View the full release here:

Technavio has published a new report on the global transplantation market from 2017-2021. (Graphic: Business Wire)

This research report titled ‘Global Transplantation Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. The development of new and improved transplantation products, including tissue products, tissue typing technology, and surgical medical instruments are driving the growth of the market.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Based on procedures, the report categorizes the global transplantation market into the following segments:

  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantations

The top three revenue-generating procedure segments in the global transplantation market are discussed below:

Kidney transplantation

Kidney transplantation is a surgical procedure that involves the replacement of a diseased kidney with a healthy kidney. The global transplantation market by kidney transplants occupy a majority 50% of the overall shares ,” says Srinivas Sashidhar, a lead analyst at Technavio for life science research tools research.

Based on the source of the donor organ, kidney transplants are classified into deceased donor and living donor transplantation. Kidney transplantation is carried out to treat severe conditions such as end-stage renal disease (ESRD), repeated urinary infections, renal failure, polycystic kidney disease, glomerulonephritis, and hemolytic uremic syndrome.

Liver transplantation

Liver transplants involve the replacement of a diseased or injured liver with a whole liver or a healthy segment from a donor. Chronic liver failure is usually caused in adults due to cirrhosis caused by hepatitis C or long-term alcohol consumption. In children, it is usually caused by biliary atresia.

The advances in liver transplants such as the streamlining of pre-transplant serological testing, bio-analytical testing, and genomic services have raised success rates of the procedures. Also, governments provide financial assistance and reimbursements to aid patients in receiving timely treatment.

Heart transplantation

Heart transplants are performed on patients suffering from severe coronary artery disease or end-stage heart failure. The leading causes of heart failure include coronary heart disease, congenital heart defects, damaged heart valves or heart muscles, or viral infections of the heart.

Heart transplant surgeries results in improved standard of living for the patients and extends their lifespan by up to 10 years. The improving reimbursement scenario is expected to positively impact the market segment,” says Srinivas.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • Bio-Rad Laboratories
  • Illumina
  • Thermo Fisher Scientific

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like medical imaging , oncology, andvaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at

View source version on

Business Wire

Last updated on: 03/05/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.